Alex Nivorozhkin
Chief Tech/Sci/R&D Officer chez CYBIN INC.
Fortune : 2 M $ au 31/03/2024
Profil
Alex Nivorozhkin is the founder of Adelia Therapeutics, Inc. founded in 2020, where he holds the title of Chief Executive Officer & Director.
He currently holds positions as a Member at the International Cannabinoid Research Society, Chief Operating Officer at Amorsa Therapeutics, Inc., and Chief Scientific Officer at Cybin, Inc. since 2020.
Dr. Nivorozhkin's former positions include Head-Medicinal Chemistry at EPIX Pharmaceuticals, Inc. and Inotek Pharmaceuticals Corp., Program Manager at The General Hospital Corp., Member at Boston BioCom LLC, Senior Program Manager at Center For Integration of Medicine & Innovative Technology, and Co-Founding Member at Neo-Advent Technologies LLC.
Dr. Nivorozhkin holds a doctorate degree from Rostov State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CYBIN, INC.
1,28% | 05/04/2024 | 5 250 682 ( 1,28% ) | 2 M $ | 31/03/2024 |
Postes actifs de Alex Nivorozhkin
| Sociétés | Poste | Début |
|---|---|---|
| CYBIN INC. | Chief Tech/Sci/R&D Officer | 01/12/2020 |
Adelia Therapeutics, Inc.
 Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Founder | 01/01/2020 |
Amorsa Therapeutics, Inc.
 Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amorsa Therapeutics, Inc. is an American neuron pharmaceutical company. The private company is based in Southborough. | Chief Operating Officer | - |
| International Cannabinoid Research Society | Corporate Officer/Principal | - |
Anciens postes connus de Alex Nivorozhkin
| Sociétés | Poste | Fin |
|---|---|---|
| Center For Integration of Medicine & Innovative Technology | Corporate Officer/Principal | - |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Corporate Officer/Principal | - |
| Neo-Advent Technologies LLC | Corporate Officer/Principal | - |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Formation de Alex Nivorozhkin
| Rostov State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CYBIN INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
| Center For Integration of Medicine & Innovative Technology | |
| International Cannabinoid Research Society | |
Amorsa Therapeutics, Inc.
Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amorsa Therapeutics, Inc. is an American neuron pharmaceutical company. The private company is based in Southborough. | Health Technology |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Health Technology |
| Neo-Advent Technologies LLC | |
Boston BioCom LLC
 Boston BioCom LLC Pharmaceuticals: MajorHealth Technology Boston BioCom LLC develops and commercializes life science technologies. The company was founded by Alexey V. Eliseev in 2007 is headquartered in Boston, MA. | Health Technology |
